维普期刊资源整合服务平台（V6.5）

61篇 您的检索式：作者名="Yothers G"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Phase Iff trialassessing bevacizumab in stages II and III carcinoma ofthe colon: results of NSABP protocol C-08显示文摘	Allegra CJ Yothers G O'Connell MJ	2011	J Clin Oncol2011，29，1：	1
2	Final results from NSABP protocol R-04: Neoadjuvant chemoradiation (RT) comparing continuous infusion (CIV) 5-FU with capecitabine(Cape) with or without oxaliplatin(Ox) in pa- tients with stage II and III rectal cancer显示文摘	Allegra CJ Yothers G O'Connell MJ	2014	J Clin Oncol2014，，：	1
3	Quality of llfe in operable colon cancer patients receiving oral compared with intravenous chemotherapy:results from National Surgical Adjuvant Breast and Bowel Project Trial C-06显示文摘	Kopec JA Yothers G Ganz PA	2007	J Clin Oncol2007，25，4：	1
4	Long-term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adjuvant therapy for colon cancer: results from National Surgical Adjuvant Breast and Bowel Project trials C-07 and LTS-01显示文摘	Kidwe\|l KM Yothers G Ganz PA	2012	Cancer2012，118，：	1
5	Adjuvant therapy for very young women with breast cancer: need for tailored treatments 显示文摘	Goldhirsch A Gelber RD Yothers G	2001	J Natl Cancer Inst Monogr2001，，30：	1
6	Body mass index andoutcomes in patients who receive adjuvant chemotherapy for coloncancer显示文摘	Dignam JJ Polite BN Yothers G	2006	J Natl Cancer Inst2006，98，22：	1
7	Long-term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adjuvant therapy for coloncancer: results from National Surgical Adjuvant Breast and Bowel Project trials C-07 and LTS-O1显示文摘	Kidwell KM Yothers G Ganz PA	2012	Cancer2012，118，22：	1
8	Multiagent regimens for metastatic colorectal cancer:if some is good,more must be better显示文摘	Allegra C George T Jr Yothers G	2011	J Natl Cancer Inst2011，103，：	1
9	Assessment of cardiac dys- function in a randomized trial comparing doxorubicin and cyclophos- phamide followed by paclitaxel, with or without trastuzumab as adju- vant therapy in node-pasitive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31 显示文摘	Tan-Chiu E Yothers G Romond E	2005	J Clin Onco12005，23，31：	1
10	Initial safety report of NSABP C-08 :a randomized phase Ⅲ study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage Ⅱ or Ⅲ colon cancer显示文摘	Allegra CJ Yothers G O'Connell M J	2009	J Clin Oncol2009，27，20：	1
11	Capsule biosynthesis and bas-ic metabolism in Streptococcus pneumoniae are linked through the cellularphosphoglucomutase显示文摘	HARDY G G CAIMANO M J YOTHER J	2000	J Bacteriol2000，182，：	1
12	Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage Ⅱ and Ⅲ colon cancer: results from NSABP C-07显示文摘	Kuebler JP Wieand HS O’Connell MJ Smith RE Colangelo LH Yothers G Petrelli NJ Findlay MP Seay TE Atkins JN Zapas JL Goodwin JW Fehrenbacher L Ramanathan RK Conley BA Flynn PJ Soori G Colman LK Levine EA Lanier KS Wolmark N	2007	J Clin Oncol2007，25，16：	1
13	Bevacizumab in Stage Ⅱ-Ⅲ Colon Cancer: f-Year Update of the National Surgical Adjuvant Breast and Bowel Project C-08 Trial显示文摘	Allegra CJ Yothers G O'Connell M J	2013	Journal of Clinical Oncology2013，31，3：	1
14	Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclopbosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31显示文摘	Tan-Chiu E Yothers G Romond E	2005	J Clin Oncol2005，23，31：	1
15	Assessment of cardiac dysfunction in a randomized trial comparing doxorubiein and cyclo- phosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31 显示文摘	Tan-Chiu E Yothers G Romond E	2005	J Clin Oneol2005，23，31：	1
16	Primary mFOLFOX6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of NSABP trial C-10显示文摘	McCahill LE Yothers G Sharif S	2012	J Clin Oncol2012，30，26：	1
17	Phase DI trialassessing bevacizumab in stages II and IH carcinoma ofthe colon: results of NSABP protocol C-08显示文摘	Allegra CJ Yothers G 0’Connell MJ 过 al	2011	J Clin On-co/2011，29，1：	1
18	Phase III Trial As- sessing Bevacizumab in Stages II and III Carcinoma of the Co- lon: Results of NSABP Protocol C-08 显示文摘	Allegra CJ Yothers G O'Connell MJ	2011	J Clin Oncol2011，29，1：	1
19	Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastu- zumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31 显示文摘	Tan-Chiu E Yothers G Romond E	2005	J Clin Oncol2005，23，31：	1
20	Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon : Results of NSABP Protocol C-08 显示文摘	Allegra C J Yothers G 0' Connell M J	2011	J Clin Oncol2011，29，1：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示